Dermatology Clinical Research San Antonio, TX - 78229

Dermatology Clinical Research is categorized under Dermatologists in San Antonio, TX and active since 2010.

Dermatology Clinical Research was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Dermatologists business, which does work in the B2C market, and is classified as a Dermatologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Christopher Ganem at the company’s single location by writing to 7810 Louis Pasteur Drive, San Antonio, Texas TX 78229 or by phoning (210) 692-1382. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dermatology Clinical Research
Contact Person: Christopher Ganem
Address: 7810 Louis Pasteur Drive, San Antonio, Texas 78229
Phone Number: (210) 692-1382
Website Address: dermresearch.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Dermatologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Dermatology Clinical Research was started in 2010 to provide professional Dermatologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Christopher Ganem for inquiries that concern Dermatology Clinical Research by calling the company number (210) 692-1382, as your correspondence is most welcome. Additionally, the physical location of the single location of Dermatology Clinical Research can be found at the coordinates 29.50954,-98.56845 as well as the street address 7810 Louis Pasteur Drive in San Antonio, Texas 78229.

For its online presence, you may visit Dermatology Clinical Research’s website at dermresearch.com and engage with its social media outlets through on Twitter and on Facebook.